-
Its back to the research drawing board in the search for more treatment options for genital herpes. A clinical trial of an experimental drug, resiquimod, has been suspended since preliminary data showed it was not as effective as expected.
-
The news is in from the worlds first large-scale trial of a HIV vaccine, and it isnt good: The vaccine failed to achieve a statistically significant reduction of HIV infection within its study population as a whole.
-
Epidemiological evidence presented at a recent Bethesda, MD-based National Cancer Institute (NCI) workshop could help end a longstanding debate on the question of induced abortion and risk of breast cancer.
-
Scientists recently conducted an international survey to explore womens willingness to use a contraceptive that induces amenorrhea.
-
Four years after its initial announcement to revive the Today contraceptive sponge, the company responsible for its rebirth finally has released the product in Canada and says it is pressing for Food and Drug (FDA) approval to market the device over the counter in the United States.
-
Without fanfare, the Bush administration has issued an important report to Congress on nondirective pregnancy options counseling in family planning clinics. Specifically, the report sought to assess the extent to which adoption information and referral is provided as part of nondirective counseling in publicly funded clinics.
-
-
Use of Hip Protectors in Nursing Homes: Cluster Randomized Controlled Trial; Disclosing Unanticipated Outcomes and Medical Errors; Non-Invasive Positive Pressure Ventilation to Treat Respiratory Failure Resulting from Exacerbations of COPD
-
Eletriptan is the newest triptan to be approved for the treatment of migraine headaches. It marks the seventh entry into this crowded market.
-
Initiation of antihypertensive treatment involving ACE inhibitors in older subjects, particularly men, appears to lead to better outcomes than treatment with diuretic agents, despite similar reductions of blood pressure.